About MIMOSA Diagnostics Inc
MIMOSA Diagnostics Inc. is a medical technology company that has developed MIMOSA Pro, a handheld multispectral imaging device that enables non-invasive assessment of tissue health. The company's core innovation transforms traditionally large, 12-foot-tall near-infrared spectroscopy machines into a portable, palm-sized device that clinicians can use at the bedside or in remote care settings. MIMOSA Pro uses near-infrared (NIR) and infrared light to measure tissue oxygen saturation and temperature beneath the skin surface, providing real-time insights into tissue perfusion and health status that are not visible to the naked eye. The technology serves multiple clinical applications including wound care management, post-operative monitoring, peripheral vascular disease assessment, burn depth evaluation, and pediatric cardiac surgery monitoring. The device is particularly valuable for assessing diabetic foot ulcers, monitoring surgical flaps, and triaging patients at risk of tissue complications. MIMOSA Pro integrates with a secure cloud-based web portal that enables remote consultation between specialists and point-of-care clinicians, facilitating communication and longitudinal tracking of patient physiology. The company's mission centers on reshaping equity in healthcare by bringing expert-level tissue assessment capabilities to diverse care settings including hospitals, group practices, home care, and emergency field situations. By standardizing tissue health assessment regardless of clinician training level, MIMOSA Diagnostics aims to enable earlier diagnosis of vascular complications and reduce catastrophic outcomes such as amputations.
Mission & Story
Mission
Reshaping equity in healthcare
Clinical Focus
Medical conditions and clinical areas addressed by MIMOSA Diagnostics Inc.
Who It Serves
Social & Media
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 45 →
Aiforia
Aiforia provides AI-powered digital pathology solutions for clinical diagnostics and research. The company offers cloud-based deep learning tools and CE-IVD marked clinical suites for analyzing pathology images across multiple cancer types, serving pathologists, researchers, and diagnostic laboratories worldwide.
Aignostics
Aignostics develops AI-powered pathology solutions for precision medicine, specializing in tumor microenvironment analysis from H&E-stained whole slide images. The company serves life sciences companies and academic researchers with foundation models and custom analytics services.
Aiosyn
Aiosyn develops AI-powered computational pathology software that integrates into standard digital pathology workflows. The company specializes in deep learning solutions for cancer and chronic kidney disease diagnostics, serving clinical laboratories, biopharma, and CROs.
AIxMed
AIxMed develops AI-powered computational cytology platforms for cancer detection and diagnosis. The company's flagship product AIxURO analyzes urine cytology for bladder cancer, with additional platforms in development for thyroid, cervical, and lung cancer screening.
Akoya Biosciences
Akoya Biosciences, now part of Quanterix, provides spatial biology solutions for high-plex tissue analysis. The company develops instruments, assays, and software for spatial proteomics research, enabling researchers to map biomarkers at single-cell resolution in tissue samples.
Caris Life Sciences
Caris Life Sciences is a leading precision medicine company that provides comprehensive molecular profiling for cancer patients. The company combines genomic, transcriptomic, and proteomic data with AI to deliver personalized treatment insights for oncologists and patients.
CellaVision
201-500 employees
CellaVision is a world-leading provider of digital hematology microscopy solutions covering analyzers, instruments, reagents, and software. The company automates workflows in hematology laboratories of all sizes for human and animal blood and body fluid sample analysis.
Clever Culture Systems
Clever Culture Systems develops AI-powered automated microbiology culture plate reading technology for pharmaceutical and clinical laboratories. Their flagship product, APAS Independence, automates the imaging, interpretation, and reporting of microbial growth on culture plates.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.